In line, BiP levels of 2-DG resistant vs. sensitive breast cancer cells are elevated [27] and BiP knock-down sensitizes ALL cells to 2-DG-induced cell death [55]. This evidence concerns the gene HSPA5 and acute lymphoblastic leukemia.